1. Timilsina, Uddhav, Umthong, Supawadee, Lynch, Brian, Stablewski, Aimee, Stavrou, Spyridon. 2020. SERINC5 Potently Restricts Retrovirus Infection In Vivo. In mBio, 11, . doi:10.1128/mBio.00588-20. https://pubmed.ncbi.nlm.nih.gov/32665269/
2. Usami, Yoshiko, Wu, Yuanfei, Göttlinger, Heinrich G. 2015. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. In Nature, 526, 218-23. doi:10.1038/nature15400. https://pubmed.ncbi.nlm.nih.gov/26416733/
3. de Sousa-Pereira, Patrícia, Abrantes, Joana, Bauernfried, Stefan, Fackler, Oliver T, Baldauf, Hanna-Mari. 2018. The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists. In The Journal of general virology, 100, 278-288. doi:10.1099/jgv.0.001201. https://pubmed.ncbi.nlm.nih.gov/30566072/
4. Jin, Steven W, Mwimanzi, Francis M, Mann, Jaclyn K, Brumme, Zabrina L, Brockman, Mark A. 2020. Variation in HIV-1 Nef function within and among viral subtypes reveals genetically separable antagonism of SERINC3 and SERINC5. In PLoS pathogens, 16, e1008813. doi:10.1371/journal.ppat.1008813. https://pubmed.ncbi.nlm.nih.gov/32925973/
5. Olety, Balaji, Usami, Yoshiko, Wu, Yuanfei, Peters, Paul, Göttlinger, Heinrich. 2023. AP-2 Adaptor Complex-Dependent Enhancement of HIV-1 Replication by Nef in the Absence of the Nef/AP-2 Targets SERINC5 and CD4. In mBio, 14, e0338222. doi:10.1128/mbio.03382-22. https://pubmed.ncbi.nlm.nih.gov/36622146/
智鼠故事 
